Murakami Y - Search Results

1

MicroRNA expression in hepatocellular carcinoma after the eradication of chronic hepatitis virus C infection using interferon therapy.

Tamori A, Murakami Y, Kubo S, Itami S, Uchida-Kobayashi S, Morikawa H, Enomoto M, Takemura S, Tanahashi T, Taguchi YH, Kawada N. Tamori A, et al. Among authors: murakami y. Hepatol Res. 2016 Mar;46(3):E26-35. doi: 10.1111/hepr.12518. Epub 2015 Apr 27. Hepatol Res. 2016. PMID: 25788219

2

Role of miR-19b and its target mRNAs in 5-fluorouracil resistance in colon cancer cells.

Kurokawa K, Tanahashi T, Iima T, Yamamoto Y, Akaike Y, Nishida K, Masuda K, Kuwano Y, Murakami Y, Fukushima M, Rokutan K. Kurokawa K, et al. Among authors: murakami y. J Gastroenterol. 2012 Aug;47(8):883-95. doi: 10.1007/s00535-012-0547-6. Epub 2012 Mar 1. J Gastroenterol. 2012. PMID: 22382630

3

Comprehensive miRNA expression analysis in peripheral blood can diagnose liver disease.

Murakami Y, Toyoda H, Tanahashi T, Tanaka J, Kumada T, Yoshioka Y, Kosaka N, Ochiya T, Taguchi YH. Murakami Y, et al. PLoS One. 2012;7(10):e48366. doi: 10.1371/journal.pone.0048366. Epub 2012 Oct 31. PLoS One. 2012. PMID: 23152743 Free PMC article.

4

The expression level of miR-18b in hepatocellular carcinoma is associated with the grade of malignancy and prognosis.

Murakami Y, Tamori A, Itami S, Tanahashi T, Toyoda H, Tanaka M, Wu W, Brojigin N, Kaneoka Y, Maeda A, Kumada T, Kawada N, Kubo S, Kuroda M. Murakami Y, et al. BMC Cancer. 2013 Mar 4;13:99. doi: 10.1186/1471-2407-13-99. BMC Cancer. 2013. PMID: 23496901 Free PMC article.

5

Analysis of circulating microRNA by microarray in liver disease.

Murakami Y, Tanahashi T. Murakami Y, et al. Methods Mol Biol. 2013;1024:173-82. doi: 10.1007/978-1-62703-453-1_13. Methods Mol Biol. 2013. PMID: 23719950

6

Principal component analysis based feature extraction approach to identify circulating microRNA biomarkers.

Taguchi YH, Murakami Y. Taguchi YH, et al. Among authors: murakami y. PLoS One. 2013 Jun 24;8(6):e66714. doi: 10.1371/journal.pone.0066714. Print 2013. PLoS One. 2013. PMID: 23874370 Free PMC article.

7

Adjuvant epoetin-β with peginterferon-α and ribavirin in Japanese ribavirin-intolerant relapsed patients with chronic hepatitis C genotype 2.

Enomoto M, Morikawa H, Murakami Y, Tamori A, Kawada N. Enomoto M, et al. Among authors: murakami y. Hepatol Res. 2014 Oct;44(10):E290-6. doi: 10.1111/hepr.12257. Epub 2013 Nov 21. Hepatol Res. 2014. PMID: 24119110

8

Cytoglobin is expressed in hepatic stellate cells, but not in myofibroblasts, in normal and fibrotic human liver.

Motoyama H, Komiya T, Thuy le TT, Tamori A, Enomoto M, Morikawa H, Iwai S, Uchida-Kobayashi S, Fujii H, Hagihara A, Kawamura E, Murakami Y, Yoshizato K, Kawada N. Motoyama H, et al. Among authors: murakami y. Lab Invest. 2014 Feb;94(2):192-207. doi: 10.1038/labinvest.2013.135. Epub 2013 Dec 2. Lab Invest. 2014. PMID: 24296877 Free article.

9

Interferon-α/β for treatment of chronic hepatitis C infection in the era of direct-acting antiviral agents.

Enomoto M, Tamori A, Murakami Y, Kawada N. Enomoto M, et al. Among authors: murakami y. Hepatol Res. 2014 Apr;44(4):371-6. doi: 10.1111/hepr.12289. Epub 2014 Jan 23. Hepatol Res. 2014. PMID: 24330005

10

Prospective long-term study of hepatitis B virus reactivation in patients with hematologic malignancy.

Tamori A, Hino M, Kawamura E, Fujii H, Uchida-Kobayashi S, Morikawa H, Nakamae H, Enomoto M, Murakami Y, Kawada N. Tamori A, et al. Among authors: murakami y. J Gastroenterol Hepatol. 2014 Sep;29(9):1715-21. doi: 10.1111/jgh.12604. J Gastroenterol Hepatol. 2014. PMID: 24730465

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,152 results

Search Page

Filters